论文部分内容阅读
目的分析依达拉奉联合丹红治疗急性脑梗死的临床疗效。方法急性脑梗死40例给予依达拉奉针剂30 mg加入氯化钠溶液100 ml静脉滴注,30 min滴完,2次/d;丹红40 ml加入5%葡萄糖250 ml静脉滴注,4~6 h滴完,2次/d,共14 d。并设对照组40例,给予抗血小板制剂、舒血宁、胞二磷胆碱,疗程14 d。结果两组治疗后神经功能缺损评分疗效均有统计学差异(P<0.01,P<0.05)。结论依达拉奉联合丹红治疗急性脑梗死疗效明显。
Objective To analyze the clinical efficacy of edaravone combined with Danhong in the treatment of acute cerebral infarction. Methods 40 cases of acute cerebral infarction were treated with edaravone 30 mg intravenously by adding 100 ml of sodium chloride solution for 30 min, 2 times / d, adding 40 ml of Danhong to 250 ml of 5% glucose, 4 ~ 6 h drip finished, 2 times / d, a total of 14 d. Forty patients in control group were given antiplatelet agents, Shuxuening, Citicoline, and the course of treatment was 14 days. Results The scores of neurological deficit scores after treatment in both groups were significantly different (P <0.01, P <0.05). Conclusion Edaravone combined with Danhong treatment of acute cerebral infarction obvious effect.